The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Often change of advisor when looking for more cash around the market. I hope not.
Don't know what to say about this one. I sold out at the end of May, necessity for a house purchase, having made quite a loss anyway, but clearly 6.9 is better than 4.1 where it now stands.
Not a single comment after the half year results: everyone depressed, or everyone left? Looks like Rivaldo's out: he'll usually comment on anything material.
What looks to me like a large Baronsmead purchase in July didn't move the share price at all, and excited no comment, so I must be misunderstanding it.
I could buy back in now, it's very very low, but there seems to be a total dearth of any good news at all.
Any thoughts anyone?
I would buy more if SKIN was cut adrift
Although I was a holder here once I can't bring myself to buy back here even though it tempts me, after having one illiquid delister already this year (svca) I am always fearful of another.
Maybe on some good news.....
With respect that was a distressed seller. I can sell my entire holding for 5.9. I expect you will come back and agree with me after the interimns due by end of Sep.
Looks like a bargain price at this level
An AGM. An RNS. Controversial motions denied. Not a post here or a share traded. This is the most unloved interesting company on AIM
I will be very interested to hear opinions of the vibe of the company from anybody that went to the AGM
An AGM a resolution that looks like it was for getting hold of cash and yet no trades and no posts here. This must be the most unloved interesting company on a i m
From Hybridan this morning: "@VennLifeScience (VENN) delivers a solid set of full year numbers. EBITDA more than doubling to �1.0m! In a very strong place to deliver on future growth. @HybridianLLP" And Davy now forecast �1.1m EBITDA for this year - not bad for a �4.3m m/cap company: Https://www.davy.ie/research/public/article.htm?id=ST2_8081_1.xml.htm "FY results: margin expansion drives EBITDA growth May 17 2018 DAVY VIEW Venn has started to benefit from business integration initiatives and infrastructure investments made in 2017. Greater operational efficiency has driven margin expansion and EBITDA growth. With a full service capability spanning early and late phase clinical projects, we think there is scope to develop new business lines and further increase margins. Additionally, management focus on M&A opportunities has the potential to accelerate growth. We forecast FY 2018 EBITDA of �1.1m and remain �Outperform�."
The results looked mildly encouraging. Turnover of �17.8m and �1.0m underlying EBITDA is certainly indicative of potential relative to a �4.3m m/cap if VENN's management continue to simplify and transform the company as they have been doing. Especially given they have �1.2m net cash to finance working capital and (from the tone of the narrative) an acquisition. I'd largely written Integumen off almost entirely except as a very long-term possibility, but I do like the look of its potential acquisition/reverse. Let's hope it actually completes (there's a radio silence on this at present, which may be a good or bad thing) - if it does this could just have a material effect on VENN. VENN's outlook is indeed difficult to discern, but perhaps there are clues for those looking for positives in the outlook given the focus on "improved underlying EBITDA", profitability and sunk investment costs which will hopefully pay off this year: "During 2017 our focus has been on the delivered improved underlying EBITDA in the business through improved operational efficiencies. Additional investment in systems means that we now have both the expertise and infrastructure to profitably execute new business in scale and our focus is now on the generation of new business opportunities. We have invested significantly in business development and engaged creatively with clients to develop deeper, longer lasting partnerships and our pipeline of opportunities is healthy. We continue to see an increasing number of opportunities that require the full range of services now on offer in Venn."
Associate threshold now reduced to 22.5%. I think if they had announced that they were completely divested of that company this share would really start to shift. They shift �17+ business per year which has been consistent for the last 2 or 3 years but cannot seem to convert that into a profit. I am interested to see where this finishes today. 8:20 and no trades so far!
Is starting to climb before results and trading statement later this week. Thus could well be back to double digits by Thursday.
Any 'SKIN' murmurings anywhere? We sit and wait. Really really quietly
SP at an all time low on very thin volume, all will become much clearer after results and conference call but expecting some significant gains from here
Thanks for that. If VENN havw managed to sell off SKIN then the V SP will really take off. It has been the millstone around the neck of VENN for what, 2 years now.
RNS
Today. All time lows so could be some bounce here.
For better or for worse I have bought into VENN this morning. I did have my eye on 4.4 p but there seems to be a lot of activity this morning including a 200000 cell just now to try and keep a lid on it let's see what it is by the end of the day
Well the trading update didnt give any comfort with the cash positon of 1.2m at the end of December, that's why I sold at the time as I feared a cash call, therein could be your reason
This has come a long long long way down. Any thoughts on why so far?
exceptionally low cash too !
Is in recovery mode! Exceptionally low m cap
.... you can tell I really want to be here!
Not even an acquisition gets a comment here anymore. I had not noticed b4 that the PE ratio here is a very healthy near 15. For such a good company at getting new and repeat business it just does not earn enough from the work it does. It has very obviously declined the challenge of that 12.5 area. Anyone have any ideas chart -wise. I have a vague idea but do not hold shares here at present. Does anyone disagree with my concern that there is a big turnover but little profits. (The RNS seems to suggest that we are buying out the remaining shares of VENN France, even though the French part of VENN is losing money, through the dilution of the core business to buy out some French dude. Are they forcing him out or is he storming off. The RNS is not clear. What is the point of the buyout? Someone researched here fill us in)